Validated shRNA controlsfor results you can interpret
Controls are a critical part of a gene
silencing experiment. They enable accurate interpretation of
knockdown data and provide confidence in the specificity of the response.
Shipping Information:
Available Expression Arrest shRNAmir controls:
• Non-silencing shRNAmir construct -The Non-silencing
shRNAmir is a negative control for any transfection experiment performed
using the shRNAmir constructs. When transfected into cells it will be
processed by the endogenous RNAi pathway but its processed siRNA will
not target any mRNA in the mammalian genome. The non-silencing shRNAmir
sequence is cloned into pSM2 retroviral and the pCMV-GIN-ZEO lentiviral
vectors. This sequence has been verified to contain no homology to known
mammalian genes.
• Exogenous positive controls are a good choice as positive controls. They control for expression level of your gene in the target cell line and abundance and turnover rate of the target mRNA/protein. Available exogenous positive controls include: • eGFP shRNAmir construct: The eGFP shRNA is a positive control designed against the enhanced GFP reporter (GenBank Accession No: pEGFP U476561 ). This construct* has been validated to produce > 75% decrease in GFP fluorescence. The eGFP shRNA sequence has been cloned into pSM2 retroviral and the pCMV-GIN-ZEO lentiviral vectors.
• Luciferase shRNAmir construct: The Firefly Luciferase
shRNA is a positive control designed against pGL3 Firefly Luciferase
(Promega Cat. #E1741 ). This construct has been validated to produce
>75% decrease in luciferase activity. The luciferase shRNA sequence is
cloned into pSM2 retroviral and the pCMV-GIN-ZEO lentiviral vectors
• β -gal reporter - Monitors transfection efficiencies across wells and under different experimental conditions
Each vial of the shRNAmir control vector is shipped at a concentration of
0.5µg/µl in a total volume of 20µl, thus providing a total amount of 10µg
vector DNA. The vector DNA is shipped in a microfuge tube at room
temperature and should be stored at -20°C or -80°C.
*Designed by Dr Ricky Rickles, Harvard Medical School.
| ||||||||||||||||||||||||||||||||||||||
|
|